Valuence Merger Corp. I

Status: Pre-Deal
U=S+W/2 W=S@11.50
IPO Proceeds, $M $220.10M
IPO Date Mar 1, 2022
CEO Sung Yoon Woo
Left Lead SVB Securities
IPO Cash in Trust 103.0%
SPAC Tenor 15 + 21
IPO Sector Healthcare

Developing breakthrough technology in life sciences and/or advancing a platform for sustainable technology in Asia (excluding China, Hong Kong and Macau)

IPO Geography Asia
Target Company TBD
Deal Announced TBD
Deal Size, $M TBD
Deal Sector TBD
Deal Geography TBD
SEC Filings www.sec.gov
Approval Vote TBD
Amendment Vote May 25, 2023
VMCA VMCAU VMCAW

Sign up for Free Trial

No credit card required

Sign in for more on Valuence Merger Corp. I:

  • Structure and cap table
  • 9 directors & officers
  • 19 filings and events
  • 2 underwriters
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Sung Yoon Woo 45 CEO and Director
Sungwoo (Andrew)Hyung 36 CFO and Director
Sungsik (Sung) Lee 45 President
Dr. Gene Young Cho 38 COO
Dr. Joong Myung Cho 72 Director
John Kim 54 Director
Young Min Kim 63 Director
Gary Wunderlich 51 Director
Zhe Zhang 47 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
SVB Securities BR 16,000,000 units
Baird 4,000,000
20,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 3.68 %

Sign in to view more advisor data.

Filings

Sign in to view 19 filings.

Shareholders

Sign in to view shareholders 13F filing data.